This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

Steven H. Collis net worth and biography

Steven Collis Biography and Net Worth

CEO of Cencora

Steven H. Collis is Chairman, President and CEO of AmerisourceBergen Corporation, a global healthcare solutions leader, currently ranked No.10 on the Fortune 500. He was elected president and CEO in 2011 and chairman in 2016.

Under Mr. Collis’ leadership, AmerisourceBergen has experienced tremendous financial growth. The company’s annual revenue has jumped more than 80% during Mr. Collis’ tenure as CEO and its number of employees has risen to 21,000, with offices in more than 50 countries worldwide.

Through strategic investments and acquisitions, the company has expanded its breadth of services and solutions resulting in unprecedented customer partnerships, global reach and deep expertise that is shaping healthcare delivery.

Specifically, AmerisourceBergen’s agreement with Walgreens Boots Alliance in 2013 marked an industry first—with a national pharmacy chain turning over all its pharmaceutical distribution to a wholesaler and collaborating on a global basis for generic product sourcing. The company’s 2015 acquisition of MWI Veterinary Supply further reflect AmerisourceBergen’s ability to deliver value in diverse aspects of patient care and growing markets. As a result, the Wall Street Journal named Mr. Collis as the best performing chief executive in the Philadelphia region for 2015, and Barron’s ranked AmerisourceBergen two years in a row as No. 1 on their list of the 500 top performing companies.

What is Steven H. Collis' net worth?: The estimated net worth of Steven H. Collis is at least $75.05 million as of November 19th, 2024. Mr. Collis owns 306,752 shares of Cencora stock worth more than $75,053,012 as of November 22nd. This net worth approximation does not reflect any other assets that Mr. Collis may own. Additionally, Mr. Collis receives a salary of $5,010,000.00 as CEO at Cencora. Learn More about Steven H. Collis' net worth.
How old is Steven H. Collis?: Mr. Collis is currently 63 years old. There are 7 older executives and no younger executives at Cencora. Learn More on Steven H. Collis' age.
What is Steven H. Collis' salary?: As the CEO of Cencora, Inc., Mr. Collis earns $5,010,000.00 per year. Learn More on Steven H. Collis' salary.
How do I contact Steven H. Collis?: The corporate mailing address for Mr. Collis and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Steven H. Collis' contact information.
Has Steven H. Collis been buying or selling shares of Cencora?: Over the course of the past ninety days, Steven H. Collis has sold $10,280,441.64 in shares of Cencora stock. Most recently, Steven H. Collis sold 21,509 shares of the business's stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $242.16, for a transaction totalling $5,208,619.44. Following the completion of the sale, the chairman now directly owns 306,752 shares of the company's stock, valued at $74,283,064.32. Learn More on Steven H. Collis' trading history.
Who are Cencora's active insiders?: Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.
Are insiders buying or selling shares of Cencora?: During the last year, Cencora insiders bought shares 1 times. They purchased a total of 500 shares worth more than $109,290.00. During the last year, insiders at the sold shares 16 times. They sold a total of 10,700,964 shares worth more than $2,502,728,286.19. The most recent insider tranaction occured on November, 19th when Chairman Steven H Collis sold 21,509 shares worth more than $5,208,619.44. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.
Information on this page was last updated on 11/19/2024.

Steven H. Collis Insider Trading History at Cencora

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/19/2024	Sell	21,509	$242.16	$5,208,619.44	306,752
10/22/2024	Sell	21,509	$235.80	$5,071,822.20	285,088
7/16/2024	Sell	10,755	$222.12	$2,388,900.60	285,088
4/16/2024	Sell	10,754	$237.48	$2,553,859.92	285,088
12/12/2023	Sell	25,000	$202.15	$5,053,750.00	331,573
11/14/2023	Sell	25,000	$197.63	$4,940,750.00	331,573
10/10/2023	Sell	25,000	$185.08	$4,627,000.00	257,967
8/8/2023	Sell	10,499	$186.19	$1,954,808.81	257,967
7/11/2023	Sell	10,499	$192.87	$2,024,942.13	257,967
6/13/2023	Sell	10,499	$178.44	$1,873,441.56	257,967
5/9/2023	Sell	10,499	$169.52	$1,779,790.48	257,967
4/11/2023	Sell	10,499	$167.34	$1,756,902.66	257,967
3/14/2023	Sell	10,499	$150.00	$1,574,850.00	257,967
1/17/2023	Sell	10,499	$164.28	$1,724,775.72	257,967
12/13/2022	Sell	45,920	$165.62	$7,605,270.40	257,967
10/11/2022	Sell	11,480	$141.72	$1,626,945.60	205,178
9/13/2022	Sell	11,480	$142.40	$1,634,752.00	205,178
8/9/2022	Sell	11,480	$144.25	$1,655,990.00	205,178
7/12/2022	Sell	11,480	$142.35	$1,634,178.00	205,178
6/14/2022	Sell	11,480	$141.22	$1,621,205.60	205,178
4/12/2022	Sell	11,480	$162.11	$1,861,022.80	205,178
3/8/2022	Sell	11,480	$144.97	$1,664,255.60
2/8/2022	Sell	24,263	$141.22	$3,426,420.86
1/11/2022	Sell	24,264	$136.07	$3,301,602.48
12/14/2021	Sell	24,264	$123.95	$3,007,522.80
11/24/2021	Sell	17,168	$123.66	$2,122,994.88
11/16/2021	Sell	11,664	$124.66	$1,454,034.24
11/9/2021	Sell	24,264	$125.33	$3,041,007.12
10/12/2021	Sell	24,265	$119.79	$2,906,704.35
9/20/2021	Sell	24,265	$121.90	$2,957,903.50
8/17/2021	Sell	12,784	$120.53	$1,540,855.52
7/20/2021	Sell	12,784	$117.66	$1,504,165.44	199,609
7/13/2021	Sell	20,912	$114.90	$2,402,788.80
6/15/2021	Sell	12,784	$118.82	$1,518,994.88	201,855
6/8/2021	Sell	20,913	$117.65	$2,460,414.45	209,984
5/18/2021	Sell	12,784	$116.35	$1,487,418.40	204,101
4/20/2021	Sell	12,784	$120.07	$1,534,974.88	206,347
4/13/2021	Sell	20,914	$116.96	$2,446,101.44	214,477
3/16/2021	Sell	33,697	$112.71	$3,797,988.87	216,724
7/6/2020	Sell	19,904	$100.59	$2,002,143.36	162,026
4/6/2020	Sell	19,905	$84.75	$1,686,948.75	162,027
2/10/2020	Sell	19,905	$93.20	$1,855,146.00	162,027
1/6/2020	Sell	19,905	$84.42	$1,680,380.10	162,027
11/4/2019	Sell	19,905	$86.08	$1,713,422.40	154,484
10/7/2019	Sell	19,905	$82.12	$1,634,598.60	154,484
9/9/2019	Sell	19,905	$86.89	$1,729,545.45	154,484
8/5/2019	Sell	19,905	$89.58	$1,783,089.90	154,484
6/19/2019	Sell	107,826	$86.18	$9,292,444.68	242,405
3/1/2019	Sell	21,344	$83.62	$1,784,785.28	155,923
2/1/2019	Sell	21,350	$80.72	$1,723,372.00	155,929
1/2/2019	Sell	21,350	$73.96	$1,579,046.00	155,929
12/3/2018	Sell	21,350	$88.92	$1,898,442.00
11/1/2018	Sell	21,350	$90.92	$1,941,142.00
10/1/2018	Sell	21,350	$93.09	$1,987,471.50
9/4/2018	Sell	21,350	$88.33	$1,885,845.50	287,925
8/1/2018	Sell	21,350	$81.25	$1,734,687.50	287,925
7/2/2018	Sell	21,350	$84.63	$1,806,850.50	287,925
6/1/2018	Sell	21,350	$83.08	$1,773,758.00	287,925
5/1/2018	Sell	21,350	$88.49	$1,889,261.50
4/2/2018	Sell	21,350	$84.03	$1,794,040.50
3/1/2018	Sell	21,350	$94.25	$2,012,237.50
2/1/2018	Sell	21,350	$98.58	$2,104,683.00	287,925
1/2/2018	Sell	21,350	$93.54	$1,997,079.00
12/1/2017	Sell	21,350	$82.53	$1,762,015.50	287,925
11/1/2017	Sell	21,350	$76.94	$1,642,669.00	260,226
9/1/2017	Sell	15,000	$79.92	$1,198,800.00	253,876
7/3/2017	Sell	15,000	$94.76	$1,421,400.00	253,876
6/1/2017	Sell	15,000	$91.73	$1,375,950.00	253,876
5/1/2017	Sell	15,000	$81.98	$1,229,700.00	253,876
4/3/2017	Sell	15,000	$88.35	$1,325,250.00	253,876
2/1/2017	Sell	15,000	$87.15	$1,307,250.00	253,876
12/1/2016	Sell	15,000	$77.94	$1,169,100.00	238,876
11/1/2016	Sell	15,000	$69.85	$1,047,750.00	231,252
10/17/2016	Sell	15,000	$79.59	$1,193,850.00	231,252
12/21/2015	Sell	27,148	$102.23	$2,775,340.04	252,204
12/7/2015	Sell	9,170	$100.06	$917,550.20	243,734
12/4/2015	Sell	17,978	$100.17	$1,800,856.26	252,204
11/18/2015	Sell	25,948	$100.16	$2,598,951.68	252,204
10/27/2015	Sell	1,200	$100.97	$121,164.00	217,696
9/21/2015	Sell	27,148	$105.72	$2,870,086.56	217,696
8/20/2015	Sell	27,148	$104.27	$2,830,721.96	217,696
7/20/2015	Sell	27,148	$114.42	$3,106,274.16
6/22/2015	Sell	27,148	$112.37	$3,050,620.76
2/4/2015	Sell	145,622	$96.01	$13,981,168.22
6/11/2014	Sell	157,500	$71.83	$11,313,225.00
11/5/2013	Sell	150,000	$67.20	$10,080,000.00
5/2/2013	Sell	245,258	$54.41	$13,344,487.78

Steven H. Collis Buying and Selling Activity at Cencora

Cencora Company Overview

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Today's Range

Now: $245.02

$244.65

$247.55

50 Day Range

MA: $233.12

$219.50

$249.95

2 Week Range

Now: $245.02

$195.83

$251.56

Volume

942,788 shs

Average Volume

1,400,130 shs

Market Capitalization

$48.28 billion

P/E Ratio

32.63

Dividend Yield

0.91%

Beta

0.44

Missed Nvidia? Watch this ASAP

From Brownstone Research | Ad

Click here and I’ll tell you everything you need to know.

Steven Collis Biography and Net Worth

What is Steven H. Collis' net worth?

How old is Steven H. Collis?

What is Steven H. Collis' salary?

How do I contact Steven H. Collis?

Has Steven H. Collis been buying or selling shares of Cencora?

Who are Cencora's active insiders?

Are insiders buying or selling shares of Cencora?